Graphic with text, “Introduction of Higher Strength Facilitates Growth of All Strengths” seems to highlight the benefits of stronger #opioids for sales numbers, rather than healthcare. See in #OIDAimages: images.oida-resources.jhu.edu/47a326ac-718...
Mallinckrodt used Verde's Medsaway® pouch to promote safe medication disposal. The label highlights clean water, but the image’s source focuses on minimizing “potential for diversion or accidental exposure” of prescription #opioids. See in #OIDAimages: images.oida-resources.jhu.edu/d4201f85-a10...
This "Digital Pain Diary” feature was part of the Teva Pain Portal and the company’s “Project Breakthrough” campaign to promote Fentora, a fentanyl buccal tablet. See in #OIDAimages: images.oida-resources.jhu.edu/a18f4929-aef...
This image of a marquee board reading “Don't worry everything is going to be amazing,” with a pile of pills on top of the picture, was used in a 2015 DEA Compliance presentation for Teva. See in #OIDAimages: images.oida-resources.jhu.edu/a4f2b820-fec...
“Are you seeing your patients or your fears?” was one of several messaging concepts Teva tested in 2014 for their OraGuard abuse deterrent technology. See in #OIDAimages: images.oida-resources.jhu.edu/521efc86-109...
Teva contributed “financial support, clinical input and other expertise” to the Discovery Channel’s 2015 “Pain Matters” documentary, alongside the company's launch of PainMatters.com. See more in #OIDAimages: images.oida-resources.jhu.edu/0f810f3e-0e8...
Actiq was commonly referred to as a “fentanyl lollipop.” It and other TIRF (Transmucosal Immediate-Release Fentanyl medicines) were discontinued in 2024. See this image and similar others in #OIDAimages: images.oida-resources.jhu.edu/5b8f0693-606...
One of four ad concepts tested in 2015 for Teva’s Vantrela ER (long-acting hydrocodone). This “Made for Pain” concept tested well, though feedback noted that the patient’s “life and her happy ending have to be inferred.” See more in #OIDAimages: images.oida-resources.jhu.edu/b2a02169-c91...
This ad for Mrs. Winslow’s Soothing Syrup (a morphine/alcohol blend marketed for teething pain) was in a presentation on “Regulation of Opioids: Past, Present and Future Perspectives,” by Stephen Ziegler for Teva. See more in #OIDAimages: images.oida-resources.jhu.edu/d37da1d0-64d...
An infographic compares spending on drugs in America compared with other countries. The infographic is part of a 2014 Mallinckrodt slide deck on “infographic rollout concepts.” See more in #OIDAimages: images.oida-resources.jhu.edu/dde5fa86-96d...
This illustration of pet food bowls labeled “Glaxo,” “Pfizer” and “Lilly” and filled with pills was used in a 2017 presentation prepared for Teva by the Calibre Institute for Quality Medical Education. See more in #OIDAimages: images.oida-resources.jhu.edu/dc03c05e-fd2...
Physicians were critical of Covidien sales reps in an Exalgo (oxymorphone) messaging study, with one prescriber suggesting they “look at the quality of Endo, Janssen or Purdue as the model.” See more in #OIDAimages: images.oida-resources.jhu.edu/42fb3b5e-268...
"Exalgo is covered for 8 out of 10 managed care patients without prior authorization.” Mallinckrodt touts insurance coverage of their #opioid hydromorphone drug. See more in #OIDAimages: images.oida-resources.jhu.edu/5b008194-095...
Mallinckrodt's 2006 campaign for their #opioid Magnacet featured a racecar theme: “In the Pain Relief Challenge, Magnacet is racing for the title.” See in #OIDAimages a die-cast race car clock that was one of their promotional premium items: images.oida-resources.jhu.edu/f97fe6cc-27e...
Co-pay discount programs like this Xartemis coupon helped make the oxycodone/acetaminophen drug more accessible to prescribers and patients. See more in #OIDAimages: images.oida-resources.jhu.edu/3ad1e34e-28c...
This cartoon on prescription drugs found in tap water was in a Pyramid Healthcare Solutions presentation to Mallinckrodt about Rx drug diversion. See more in #OIDAimages: images.oida-resources.jhu.edu/6b565bfd-bb5...
“Acute pain eviction notice” ad mockup for #opioid COV-795 (which would later be named Xartemis). The “pain solution specialist” was a Mallinckrodt sales VP. See more in #OIDAimages: images.oida-resources.jhu.edu/eabb6d36-32a...
We found the handwritten slide draft with help from #OIDAimages. images.oida-resources.jhu.edu/86a01bda-3f4...
An advertisement for Liquicet (liquid hydroocodone) with an illustration of a boat on the water with the name “Liquicet”. Text summarizes prescribing information for the drug.
An ad for Liquicet describes a liquid #opioid formulation, targeting younger patients. See more in #OIDAimages: images.oida-resources.jhu.edu/6aa61d1f-d42...